Manuela Gambella

Late-onset facioscapulohumeral muscular dystrophy defines a distinct clinical subgroup

Giulia Tammam, Sandra Dhifallah, Hongmei Yang, Manuela Gambella et autres

fr, us, it, nl (code pays fourni par la source)

Interleukin‐6 as a Key Biomarker in Facioscapulohumeral Dystrophy: Evidence From Longitudinal Analyses

Jonathan Pini, Emanuela Martinuzzi, Sandra Dhifallah, Abderhmane Slioui et autres

fr, mc (code pays fourni par la source)

694PNatural history of distal and myofibrillar myopathies assessed by clinical and technological outcome measures (dista-myo): longitudinal results

Sara Bortolani, Eleonora Torchia, B Ravera, V. Trombetta et autres

it, gb, fr (code pays fourni par la source)

Author Correction: Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes

Sheri Skerget, Daniel Peñaherrera, Ajai Chari, Sundar Jagannath et autres

us, es, ca (code pays fourni par la source)

794 | PATIENT‐REPORTED ADVERSE EVENTS AND HEALTH‐RELATED QUALITY OF LIFE BY CAR T‐CELL PRODUCT IN PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMAS

Fabio Efficace, Francesca Bonifazi, Pier Luigi Zinzani, Ilaria Cutini et autres

it (code pays fourni par la source)

Safety and efficacy of chronic weekly rozanolixizumab in generalized myasthenia gravis: the randomized open-label extension MG0004 study

Vera Bril, Artur Drużdż, Julian Großkreutz, Ali A. Habib et autres

ca, de, us, it, fr, jp, dk (code pays fourni par la source)

(CAR-)T cell dynamics following chimeric antigen receptor T cells for large B cell lymphoma: a translational tale

Manuela Gambella, Simona Carlomagno, Anna Maria Raiola, Simona Sivori et autres

it (code pays fourni par la source)

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Vera Bril, Artur Drużdż, Julian Großkreutz, Marion Boehnlein et autres

ca, de, us, it, fr, jp, dk, gb (code pays fourni par la source)

Supplementary Appendix from Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing

Mattia D’Agostino, Gian Maria Zaccaria, Bachisio Ziccheddu, Even H. Rustad et autres

Data from Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing

Mattia D’Agostino, Gian Maria Zaccaria, Bachisio Ziccheddu, Even H. Rustad et autres

Data from Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing

Mattia D’Agostino, Gian Maria Zaccaria, Bachisio Ziccheddu, Even H. Rustad et autres

Supplementary Appendix from Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing

Mattia D’Agostino, Gian Maria Zaccaria, Bachisio Ziccheddu, Even H. Rustad et autres